BiovaxID regulatory update

Accentia's Biovest International Inc. (OTCQB:BTVI, Tampa Fla.) subsidiary said EMA formally notified the subsidiary that an MAA for BiovaxID to treat follicular non-Hodgkin's lymphoma (NHL) is eligib...